Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Special Investigation for Vizimpro Tablets

NCT04155541 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT04155541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04155541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Special Investigation for Vizimpro Tablets
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
January 24, 2020
Completion date
April 25, 2025
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

egfr mutation-positive inoperable or reccrent nsclc